Coronary heart disease complicated with anxiety and depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years or above, regardless of gender; 2. Patients who complained of chest tightness and chest pain and were definitely diagnosed as coronary heart disease; 3. Patients who have received standardized treatment (coronary artery disease drugs, according to the needs of the patient's condition, coronary intervention treatment); 4. All the patients were assessed with the symptom Checklist-90 (SAS), depression scale (SDS), self-efficacy and quality of life scale (SF-36) to confirm that the patients had mild anxiety and depression; the patients with SAS score of 50-59 and or SDS score of 50-60 were included; 5. Patients who voluntarily sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients whose expected survival time is less than 12 months; 2. Patients with previous psychiatric history or severe depression or suicidal tendency; 3. Patients with severe cerebrovascular disease in recent 6 months; 4. Patients with malignant arrhythmias such as ventricular tachycardia, ventricular flutter and ventricular fibrillation; 5. Patients with severe cardiac insufficiency were classified as grade IV; 6. Women of childbearing age, pregnancy or lactation, or those who intend to give birth within one year; 7. Patients with serious uncontrolled respiratory, digestive, kidney, blood, infection, immune, endocrine, tumor diseases or diseases that may cause serious risk to patients; 8. Patients with morphine, alcohol and other substance abuse or dependence in recent 6 months; 9. Patients allergic to Shexiang Baoxin Pills.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the scores of anxiety;the scores of depression;the score of SF-36;adverse events;6-minute walk test;Echocardiographic data;NYHA grade; | — |
Countries
China
Contacts
The First Affiliated Hospital of Suzhou University